ALEXANDRIA, Va., June 6 -- United States Patent no. 12,279,808, issued on April 22, was assigned to Neurent Medical Ltd. (Oranmore, Ireland).
"Systems and methods for therapeutic nasal neuromodulation" was invented by David Townley (Clare, Ireland) and Brian Shields (Galway, Ireland).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition. The system includes a device including a multi-segment end effector for delivering energy to one or more target sites within the nasal cavity of the patient. The multi-segment end effector includes a first ...